Marinus Pharmaceuticals Inc (MRNS)
1.33
+0.03
(+2.31%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Cash from Investing (Quarterly): 20.88M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 20.88M |
December 31, 2023 | 6.466M |
September 30, 2023 | 11.92M |
June 30, 2023 | 5.004M |
March 31, 2023 | -52.00M |
December 31, 2022 | 0.079M |
September 30, 2022 | 106.11M |
June 30, 2022 | -0.335M |
March 31, 2022 | -0.086M |
December 31, 2021 | -0.721M |
September 30, 2021 | -0.872M |
June 30, 2021 | -0.864M |
March 31, 2021 | 1.042M |
December 31, 2020 | 2.482M |
September 30, 2020 | 2.982M |
June 30, 2020 | 0.495M |
March 31, 2020 | -6.697M |
December 31, 2019 | 1.964M |
September 30, 2019 | -0.255M |
June 30, 2019 | -2.696M |
March 31, 2019 | 4.868M |
December 31, 2018 | 14.92M |
September 30, 2018 | 5.002M |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | -0.008M |
December 31, 2017 | 0.238M |
September 30, 2017 | -24.69M |
June 30, 2017 | 1.423M |
March 31, 2017 | 1.612M |
December 31, 2016 | 0.248M |
September 30, 2016 | 1.253M |
June 30, 2016 | -1.295M |
March 31, 2016 | 1.19M |
December 31, 2015 | 0.501M |
September 30, 2015 | -4.972M |
June 30, 2015 | -0.352M |
March 31, 2015 | -1.491M |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | -0.003M |
September 30, 2013 | -0.002M |
June 30, 2013 | -0.008M |
March 31, 2013 | -0.004M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-52.00M
Minimum
Mar 2023
106.11M
Maximum
Sep 2022
4.746M
Average
0.287M
Median
Cash from Investing (Quarterly) Benchmarks
Pfizer Inc | 1.732B |
ACADIA Pharmaceuticals Inc | -14.04M |
Alnylam Pharmaceuticals Inc | -67.62M |
Regeneron Pharmaceuticals Inc | -1.687B |
Actinium Pharmaceuticals Inc | -0.011M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -37.46M |
Cash from Financing (Quarterly) | 0.257M |
Free Cash Flow | -113.98M |
Free Cash Flow Per Share (Quarterly) | -0.6589 |
Free Cash Flow to Equity (Quarterly) | -37.96M |
Free Cash Flow Yield | -155.8% |